يرجى استخدام متصفح الكمبيوتر الشخصي للوصول إلى التسجيل - تداول السعودية
حسنًا
Clear Street Initiates Coverage On Krystal Biotech with Buy Rating, Announces Price Target of $190
Krystal Biotech, Inc. -0.86%
Krystal Biotech, Inc. KRYS | 244.65 | -0.86% |
Clear Street analyst Bill Maughan initiates coverage on Krystal Biotech (NASDAQ:
KRYS) with a Buy rating and announces Price Target of $190.
